Fernández-Bravo-Rodrigo, J.; Pascual-Morena, C.; Flor-García, A.; Saz-Lara, A.; Sequí-Dominguez, I.; Álvarez-Bueno, C.; Barreda-Hernández, D.; Cavero-Redondo, I.
The Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies for the Preventive Treatment of Migraine: A Protocol for Multiple-Treatment Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2022, 19, 1753.
https://doi.org/10.3390/ijerph19031753
AMA Style
Fernández-Bravo-Rodrigo J, Pascual-Morena C, Flor-García A, Saz-Lara A, Sequí-Dominguez I, Álvarez-Bueno C, Barreda-Hernández D, Cavero-Redondo I.
The Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies for the Preventive Treatment of Migraine: A Protocol for Multiple-Treatment Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2022; 19(3):1753.
https://doi.org/10.3390/ijerph19031753
Chicago/Turabian Style
Fernández-Bravo-Rodrigo, Jaime, Carlos Pascual-Morena, Amparo Flor-García, Alicia Saz-Lara, Irene Sequí-Dominguez, Celia Álvarez-Bueno, Dolores Barreda-Hernández, and Iván Cavero-Redondo.
2022. "The Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies for the Preventive Treatment of Migraine: A Protocol for Multiple-Treatment Systematic Review and Meta-Analysis" International Journal of Environmental Research and Public Health 19, no. 3: 1753.
https://doi.org/10.3390/ijerph19031753
APA Style
Fernández-Bravo-Rodrigo, J., Pascual-Morena, C., Flor-García, A., Saz-Lara, A., Sequí-Dominguez, I., Álvarez-Bueno, C., Barreda-Hernández, D., & Cavero-Redondo, I.
(2022). The Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies for the Preventive Treatment of Migraine: A Protocol for Multiple-Treatment Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health, 19(3), 1753.
https://doi.org/10.3390/ijerph19031753
